Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, or ALS for short, is a type of motor neuron disease. It is a chronic progressive degenerative disease that affects upper motor neurons (brain, brainstem, spinal cord) and lower motor neurons (cranial nerve nuclei, anterior horn cells of the spinal cord) and the trunk, limbs, and facial muscles they control. Clinically, it often manifests as mixed paralysis with damage to upper and lower motor neurons.
-
Site of disease:
Cranio-spinal cord -
Infectious :
Not contagious -
Frequent population:
It is more common in middle-aged and elderly people over 40 years old, both men and women... -
Related symptoms:
Muscle atrophy due to disuse Dysphagia Inarthria Sensory impairment Tongue muscle atrophy -
Concurrent disease:
Related Drugs
Riluzole Tablets
Indication: For the treatment of patients with amyotrophic lateral sclerosis, it can prolong survival and/or delay the need for tracheotomy.
Manufacturer:
Jiangsu Nhwa Pharmaceutical Co., Ltd.
Riluzole Tablets
Indication: For the treatment of patients with amyotrophic lateral sclerosis, it can prolong survival and/or delay the need for tracheotomy.
Riluzole Tablets
Indication: For the treatment of patients with amyotrophic lateral sclerosis, it can prolong survival and/or delay the need for tracheotomy.
Manufacturer:
Lunan BETTER Pharmaceutical Co., Ltd.
Riluzole Tablets
Indication: For the treatment of patients with amyotrophic lateral sclerosis, it can prolong survival and/or delay the need for tracheotomy.
RILUZOLE- riluzole_tablet, film coated
Indication: Riluzole tablets are indicated for the treatment of amyotrophic lateral sclerosis (ALS). Riluzole tablets are indicated for the treatment of amyotrophic lateral sclerosis (ALS) ( 1.
Manufacturer:
Mylan Pharmaceuticals Inc.
RILUZOLE- riluzole_tablet, film coated
Indication: Riluzole tablets are indicated for the treatment of amyotrophic lateral sclerosis (ALS). Riluzole tablets are indicated for the treatment of amyotrophic lateral sclerosis (ALS) ( 1.
Manufacturer:
Mylan Pharmaceuticals Inc.
RADICAVA- edaravone_injection
Indication: RADICAVA and RADICAVA ORS are indicated for the treatment of amyotrophic lateral sclerosis (ALS).
Manufacturer:
RADICAVA ORS- edaravone
Related Ingredients